Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples